Skip to main content

Peer Review reports

From: Use of ramucirumab for various treatment lines in real-world practice of patients with advanced hepatocellular carcinoma

Original Submission
28 Jun 2022 Submitted Original manuscript
25 Nov 2022 Reviewed Reviewer Report - Seogsong Jeong
4 Dec 2022 Reviewed Reviewer Report
31 Jan 2023 Author responded Author comments - Sadahisa Ogasawara
1 Feb 2023 Author responded Author comments - Sadahisa Ogasawara
Resubmission - Version 2
31 Jan 2023 Submitted Manuscript version 2
1 Feb 2023 Author responded Author comments - Sadahisa Ogasawara
Resubmission - Version 3
1 Feb 2023 Submitted Manuscript version 3
Publishing
13 Feb 2023 Editorially accepted
11 Mar 2023 Article published 10.1186/s12876-023-02674-x

You can find further information about peer review here.

Back to article page